Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 1
1959 1
1962 5
1963 1
1964 5
1965 2
1966 3
1967 1
1968 7
1969 1
1970 4
1971 5
1972 2
1974 4
1975 4
1976 2
1977 6
1978 5
1979 7
1980 11
1981 10
1982 18
1983 15
1984 9
1985 13
1986 16
1987 16
1988 28
1989 18
1990 19
1991 22
1992 20
1993 27
1994 36
1995 26
1996 16
1997 22
1998 24
1999 44
2000 56
2001 61
2002 51
2003 52
2004 47
2005 60
2006 60
2007 69
2008 55
2009 70
2010 73
2011 107
2012 96
2013 94
2014 93
2015 110
2016 105
2017 114
2018 111
2019 105
2020 126
2021 143
2022 154
2023 93
2024 103
2025 103

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,521 results

Results by year

Filters applied: . Clear all
Page 1
MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC.
Haratake N, Ozawa H, Morimoto Y, Yamashita N, Daimon T, Bhattacharya A, Wang K, Nakashoji A, Isozaki H, Shimokawa M, Kikutake C, Suyama M, Hashinokuchi A, Takada K, Takenaka T, Yoshizumi T, Mitsudomi T, Hata AN, Kufe D. Haratake N, et al. Among authors: morimoto y. J Thorac Oncol. 2024 Mar;19(3):434-450. doi: 10.1016/j.jtho.2023.10.017. Epub 2023 Nov 3. J Thorac Oncol. 2024. PMID: 37924972 Free PMC article.
Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor Encephalitis.
Milano C, Saylam E, Papi C, Marmolejo L, Sankovic A, Reinecke R, Kerstens J, Pizzanelli C, Simabukuro MM, Benaiteau M, Joubert B, Gastaldi M, Dutra LA, Leypoldt F, Jansen M, Kawachi I, Akiyama H, Boy N, Bozzetti S, Christensen PB, Businaro P, Dinoto A, Friedman-Korn T, Fujiwara U, Fukumoto T, Fuse K, Hooshmand SI, Hurst L, Iorio R, Korn-Lubetzki I, Rodrigues AFL, Mariotto S, Michael J, Morimoto Y, Neuteboom RF, Piquet AL, Rossetti AO, Rumpler-Kreiner S, Santoro JD, Schwendinger F, Shen B, Syrbe S, Troger J, Wagner I, Bien CG, Martinez-Hernandez E, Armangue T, Höftberger R, Iizuka T, Titulaer MJ, Honnorat J, Graus F, Dalmau JO, Magaña S, Spatola M. Milano C, et al. Among authors: morimoto y. Neurol Neuroimmunol Neuroinflamm. 2025 Sep;12(5):e200453. doi: 10.1212/NXI.0000000000200453. Epub 2025 Jul 18. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 40680249 Free PMC article.
MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer.
Yamashita N, Morimoto Y, Fushimi A, Ahmad R, Bhattacharya A, Daimon T, Haratake N, Inoue Y, Ishikawa S, Yamamoto M, Hata T, Akiyoshi S, Hu Q, Liu T, Withers H, Liu S, Shapiro GI, Yoshizumi T, Long MD, Kufe D. Yamashita N, et al. Among authors: morimoto y. Mol Cancer Res. 2023 Mar 1;21(3):274-289. doi: 10.1158/1541-7786.MCR-22-0772. Mol Cancer Res. 2023. PMID: 36445328 Free PMC article.
The History of Infectious Diseases and Medicine.
Sakai T, Morimoto Y. Sakai T, et al. Among authors: morimoto y. Pathogens. 2022 Oct 4;11(10):1147. doi: 10.3390/pathogens11101147. Pathogens. 2022. PMID: 36297204 Free PMC article. Review.
Adverse effects of nanoparticles on humans.
Morimoto Y, Izumi H, Tomonaga T, Nishida C, Higashi H. Morimoto Y, et al. J Occup Health. 2025 Jan 7;67(1):uiaf002. doi: 10.1093/joccuh/uiaf002. J Occup Health. 2025. PMID: 39890621 Free PMC article. Review.
MUC1-C regulates NEAT1 lncRNA expression and paraspeckle formation in cancer progression.
Bhattacharya A, Wang K, Penailillo J, Chan CN, Fushimi A, Yamashita N, Daimon T, Haratake N, Ozawa H, Nakashoji A, Shigeta K, Morimoto Y, Miyo M, Kufe DW. Bhattacharya A, et al. Among authors: morimoto y. Oncogene. 2024 Jul;43(28):2199-2214. doi: 10.1038/s41388-024-03068-3. Epub 2024 May 27. Oncogene. 2024. PMID: 38802648 Free PMC article.
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas.
Nakashoji A, Haratake N, Bhattacharya A, Mao W, Xu K, Wang K, Daimon T, Ozawa H, Shigeta K, Fushimi A, Yamashita N, Morimoto Y, Shimokawa M, Saito S, Egloff AM, Uppaluri R, Long MD, Kufe D. Nakashoji A, et al. Among authors: morimoto y. Cancer Res Commun. 2024 May 14;4(5):1268-1281. doi: 10.1158/2767-9764.CRC-24-0011. Cancer Res Commun. 2024. PMID: 38619287 Free PMC article.
2,521 results